Allopregnanolone as a mediator of affective switching in reproductive mood disorders

Psychopharmacology

Volumn 231, Issue 17, 2014, Pages 3557-3567

  Schiller, Crystal Edler ^a   Schmidt, Peter J ^b   Rubinow, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Allopregnanolone; Animal models; Estradiol; Gonadal steroids; Neurosteroids; Postpartum depression; Premenstrual dysphoria; Progesterone; Reproductive mood disorders

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; PROGESTERONE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ELTANOLONE;

BRAIN FUNCTION; DISEASE ASSOCIATION; DISEASE MODEL; DYSPHORIA; HORMONAL REGULATION; HORMONE ACTION; HUMAN; MOOD DISORDER; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PREMENSTRUAL DYSPHORIA; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REPRODUCTION; REPRODUCTIVE MOOD DISORDER; REVIEW; VULNERABLE POPULATION; ADULT; AFFECT; FEMALE; METABOLISM; PREGNANCY; PREMENSTRUAL SYNDROME;

ADULT; AFFECT; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MOOD DISORDERS; NEUROTRANSMITTER AGENTS; PREGNANCY; PREGNANOLONE; PREMENSTRUAL SYNDROME;

EID: 84925215654     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3599-x     Document Type: Review

References (109)

1. Akwa Y, Purdy RH, Koob GF, Britton KT (1999) The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106:119-125. doi: 10.1016/S0166-4328(99)00101-1
2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Publishing, Arlington
3. Baehr E, Rosenfeld P, Miller L, Baehr R (2004) Premenstrual dysphoric disorder and changes in frontal alpha asymmetry. Int J Psychophysiol Off J Int Organ Psychophysiol 52:159-167. doi: 10.1016/j.ijpsycho.2003.06.002
4. Baller EB, Wei S-M, Kohn PD et al (2013) Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry 170:305-314. doi: 10.1176/appi.ajp.2012.12030385
5. Bannbers E, Gingnell M, Engman J et al (2012) The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. J Affect Disord 142:347-350. doi: 10.1016/j.jad.2012.04.006
6. Barbaccia ML, Roscetti G, Trabucchi M et al (1997) The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120:1582-1588. doi: 10.1038/sj.bjp.0701046
7. Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABAA receptor. Nat Rev Neurosci 6:565-575. doi: 10.1038/nrn1703
8. Berman KF, Schmidt PJ, Rubinow DR et al (1997) Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A 94:8836-8841
9. Bičíková M, Dibbelt L, Hiill M et al (2007) Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 30:227-229. doi: 10.1055/s-2007-978871
10. Bitran D, Hilvers RJ, Kellogg CK (1991) Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561:157-161. doi: 10.1016/0006-8993(91)90761-J
11. Bitran D, Purdy RH, Kellog CK (1993) Anxiolytic effect of progesterone is associated with increases in cortical alloprenanolone and GABAA receptor function. Pharmacol Biochem Behav 45:423-428. doi: 10.1016/0091-3057(93)90260-Z
12. Bixo M, Andersson A, Winblad B et al (1997) Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764:173-178. doi: 10.1016/S0006-8993(97)00455-1
13. Bloch M, Schmidt PJ, Danaceau M et al (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157:924-930
14. Bortolato M, Devoto P, Roncada P et al (2011) Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. Neuropharmacology 60:1301-1308. doi: 10.1016/j.neuropharm.2011.01.013
15. Cardona-Gomez P, Perez M, Avila J et al (2004) Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci 25:363-373. doi: 10.1016/j.mcn.2003.10.008
16. Carver CM, Reddy DS (2013) Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology (Berl) 230:151-188. doi: 10.1007/s00213-013-3276-5
17. Davidson RJ (1998) Anterior electrophysiological asymmetries, emotion, and depression: conceptual and methodological conundrums. Psychophysiology 35:607-614
18. Deeks AA, Gibson-Helm ME, Teede HJ (2010) Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 93:2421-2423. doi: 10.1016/j.fertnstert.2009.09.018
19. Deligiannidis KM, Sikoglu EM, Shaffer SA et al (2013) GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res 47:816-828. doi: 10.1016/j.jpsychires.2013.02.010
20. Djebaili M, Guo Q, Pettus EH et al (2005) The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 22:106-118. doi: 10.1089/neu.2005.22.106
21. Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446-457. doi: 10.1016/j.biopsych.2009.09.033
22. Dreher JC, Schmidt PJ, Kohn P et al (2007) Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A 104(2465)
23. Dubrovsky B (2006) Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol Biochem Behav 84:644-655. doi: 10.1016/j.pbb.2006.06.016
24. Epperson C, Haga K, Mason G et al (2002) Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59:851-858. doi: 10.1001/archpsyc.59.9.851
25. 1H-MRS study. Psychopharmacology (Berl) 186:425-433. doi: 10.1007/s00213-006-0313-7
26. Epperson CN, Steiner M, Hartlage SA et al (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169:465-475
27. Eser D, Schüle C, Baghai TC et al (2006) Neuroactive steroids in depression and anxiety disorders: clinical studies. Neuroendocrinology 84:244-254. doi: 10.1159/000097879
28. Evans J, Sun Y, McGregor A, Connor B (2012) Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 63:1315-1326. doi: 10.1016/j.neuropharm.2012.08.012
29. Fassnacht M, Schlenz N, Schneider SB et al (2003) Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2760-2766. doi: 10.1210/jc.2002-021875
30. Finocchi C, Ferrari M (2011) Female reproductive steroids and neuronal excitability. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 32(Suppl 1):S31-S35. doi: 10.1007/s10072-011-0532-5
31. Foy MR, Baudry M, Akopian GK, Thompson RF (2010) Regulation of hippocampal synaptic plasticity by estrogen and progesterone. Vitam Horm 82:219-239. doi: 10.1016/S0083-6729(10)82012-6
32. Freeman E, Rickels K, Sondheimer S, Polansky M (1990) Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 264:349-353. doi: 10.1001/jama.1990.03450030073035
33. Freeman E, Rickels K, Sondheimer S, Polansky M (1995) A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274:51-57. doi: 10.1001/jama.1995.03530010065036
34. Freeman EW, Frye CA, Rickels K et al (2002) Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 22:516-520
35. Frye CA (2009) Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology 1:S143-S161. doi: 10.1016/j.psyneuen.2009.07.005
36. Frye CA, Duncan JE (1994) Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats. Brain Res 643:194-203. doi: 10.1016/0006-8993(94)90025-6
37. Gavin NI, Gaynes BN, Lohr KN et al (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106:1071
38. Genazzani AR, Petraglia F, Bernardi F et al (1998) Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83:2099-2103. doi: 10.1210/jc.83.6.2099
39. Gilbert Evans SE, Ross LE, Sellers EM et al (2005) 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 21:268-279. doi: 10.1080/09513590500361747
40. Gingnell M, Morell A, Bannbers E et al (2012) Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Horm Behav 62:400-406. doi: 10.1016/j.yhbeh.2012.07.005
41. Girdler SS, Straneva PA, Light KC et al (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788-797
42. Glantz LA, Gilmore JH, Overstreet DH et al (2010) Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophr Res 118:292-299. doi: 10.1016/j.schres.2009.12.027
43. Goldstein JM, Jerram M, Poldrack R et al (2005) Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci Off J Soc Neurosci 25:9309-9316. doi: 10.1523/JNEUROSCI.2239-05.2005
44. Gotlib IH, Whiffen VE, Mount JH et al (1989) Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 57:269-274. doi: 10.1037/0022-006X.57.2.269
45. Griffin LD, Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci 96:13512-13517. doi: 10.1073/pnas.96.23.13512
46. Guintivano J, Arad M, Gould TD et al (2013) Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry. doi: 10.1038/mp.2013.62
47. He J, Evans C-O, Hoffman SW et al (2004) Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 189:404-412. doi: 10.1016/j.expneurol.2004.06.008
48. Huo L, Straub RE, Roca C et al (2007) Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 62:925-933. doi: 10.1016/j.biopsych.2006.12.019
49. Kehoe P, Mallinson K, McCormick CM, Frye CA (2000) Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Dev Brain Res 124:133-136. doi: 10.1016/S0165-3806(00)00106-1
50. Klatzkin RR, Leslie Morrow A, Light KC et al (2006) Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 31:1208-1219. doi: 10.1016/j.psyneuen.2006.09.002
51. Lawrie TA, Herxheimer A, Dalton K (2000) Oestrogens and progestogens for preventing and treating postnatal depression. Cochrane Database Syst Rev CD001690. doi: 10.1002/14651858.CD001690
52. Licinio J, Wong ML (1999) The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4:317-327
53. MacKenzie G, Maguire J The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders. Psychopharmacology (Berl) 1-10. doi: 10.1007/s00213-013-3423-z
54. Maguire J, Mody I (2008) GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron 59:207-213. doi: 10.1016/j.neuron.2008.06.019
55. Maguire JL, Stell BM, Rafizadeh M, Mody I (2005) Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8:797-804
56. Maguire J, Ferando I, Simonsen C, Mody I (2009) Excitability changes related to GABAA receptor plasticity during pregnancy. J Neurosci 29:9592-9601. doi: 10.1523/JNEUROSCI.2162-09.2009
57. Mahon P, Payne J, MacKinnon D et al (2009) Genome-wide linkage and follow-up association study of postpartum mood symptoms. Am J Psychiatry 166:1229-1237. doi: 10.1176/appi.ajp.2009.09030417
58. Majewska MD, Harrison NL, Schwartz RD et al (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007
59. Matsui D, Sakari M, Sato T et al (2002) Transcriptional regulation of the mouse steroid 5α-reductase type II gene by progesterone in brain. Nucleic Acids Res 30:1387-1393. doi: 10.1093/nar/30.6.1387
60. McEwen BS (2002) Basic neurobiology of ovarian steroids: clinical implications. Dialogues Clin Neurosci 4:163-176
61. Monteleone P, Luisi S, Tonetti A et al (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol Eur Fed Endocr Soc 142:269-273
62. Morrow AL, Devaud LL, Purdy RH, Paul SM (1995) Neuroactive steroid modulators of the stress response. Ann N Y Acad Sci 771:257-272. doi: 10.1111/j.1749-6632.1995.tb44687.x
63. Moses-Kolko EL, Perlman SB, Wisner KL et al (2010) Abnormally reduced dorsomedial prefrontal cortical activity and effective connectivity with amygdala in response to negative emotional faces in postpartum depression. Am J Psychiatry 167:1373-1380
64. Moses-Kolko EL, Fraser D, Wisner KL et al (2011) Rapid habituation of ventral striatal response to reward receipt in postpartum depression. Biol Psychiatry 70:395-399
65. O'Hara MW, Swain AM (1996) Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry 8:37-54. doi: 10.3109/09540269609037816
66. Patchev VK, Shoaib M, Holsboer F, Almeida OFX (1994) The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62:265-271. doi: 10.1016/0306-4522(94)90330-1
67. Patchev VK, Hassan AHS, Holsboer F, Almeida OFX (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15:533-540. doi: 10.1016/S0893-133X(96)00096-6
68. Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA (2005) Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 85:275-282. doi: 10.1016/j.jad.2004.10.004
69. Pluchino N, Russo M, Santoro AN et al (2013) Steroid hormones and BDNF. Neuroscience 239:271-279. doi: 10.1016/j.neuroscience.2013.01.025
70. Protopopescu X, Pan H, Altemus M et al (2005) Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A 102:16060-16065. doi: 10.1073/pnas.0502818102
71. Protopopescu X, Tuescher O, Pan H et al (2008) Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 108:87-94. doi: 10.1016/j.jad.2007.09.015
72. Rapkin AJ, Morgan M, Goldman L et al (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709-714. doi: 10.1016/S0029-7844(97)00417-1
73. Rapkin AJ, Berman SM, Mandelkern MA et al (2011) Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry 69:374-380. doi: 10.1016/j.biopsych.2010.09.029
74. Romeo E, Ströhle A, Spalletta G et al (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913
75. Rubinow DR, Girdler SS (2011) Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater. Depress Anxiety 28:282-296. doi: 10.1002/da.20810
76. Sampson GA (1979) Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. Br J Psychiatry 135:209-215. doi: 10.1192/bjp.135.3.209
77. Sayeed I, Parvez S, Wali B et al (2009) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res 1263:165-173. doi: 10.1016/j.brainres.2009.01.045
78. Schmidt PJ, Purdy RH, Moore PH et al (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256-1260. doi: 10.1210/jc.79.5.1256
79. Schmidt PJ, Nieman LK, Danaceau MA et al (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209-216. doi: 10.1056/NEJM199801223380401
80. Schüle C, Romeo E, Uzunov DP et al (2005) Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity. Mol Psychiatry 11:261-272. doi: 10.1038/sj.mp.4001782
81. Schüle C, Baghai TC, di Michele F et al (2007) Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. Psychoneuroendocrinology 32:669-680. doi: 10.1016/j.psyneuen.2007.04.004
82. Schüle C, Eser D, Baghai TC et al (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191:55-77. doi: 10.1016/j.neuroscience.2011.03.025
83. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M et al (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16:751-762. doi: 10.1038/mp.2010.52
84. Shen H, Gong QH, Aoki C et al (2007) Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty. Nat Neurosci 10:469-477. doi: 10.1038/nn1868
85. Shimizu E, Hashimoto K, Okamura N et al (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75. doi: 10.1016/S0006-3223(03)00181-1
86. Silverman ME, Loudon H, Safier M et al (2007) Neural dysfunction in postpartum depression: an fMRI pilot study. CNS Spectr 12:853-862
87. Smith SS, Gong QH, Hsu FC et al (1998a) GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392:926-930
88. Smith SS, Gong QH, Li X et al (1998b) Withdrawal from 3α-OH-5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety. J Neurosci 18:5275-5284
89. Smith MJ, Adams LF, Schmidt PJ et al (2002) Effects of ovarian hormones on human cortical excitability. Ann Neurol 51:599-603. doi: 10.1002/ana.10180
90. Smith MJ, Adams LF, Schmidt PJ et al (2003) Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54:757-762. doi: 10.1016/S0006-3223(02)01924-8
91. Smith SS, Ruderman Y, Frye C et al (2006) Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology (Berl) 186:323-333. doi: 10.1007/s00213-005-0168-3
92. Sohrabji F, Greene LA, Miranda RC, Toran-Allerand CD (1994a) Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol 25:974-988. doi: 10.1002/neu.480250807
93. Sohrabji F, Miranda RC, Toran-Allerand CD (1994b) Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci Off J Soc Neurosci 14:459-471
94. Sorwell KG, Kohama SG, Urbanski HF (2012) Perimenopausal regulation of steroidogenesis in the nonhuman primate. Neurobiol Aging 33:1487.e1-1487.e13. doi: 10.1016/j.neurobiolaging.2011.05.0
95. Ströhle A, Romeo E, Hermann B et al (1999) Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274-277. doi: 10.1016/S0006-3223(98)00328-X
96. Sundström Poromaa I, Smith S, Gulinello M (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Womens Ment Health 6:23-41. doi: 10.1007/s00737-002-0147-1
97. Sundström I, Bäckström T (1998) Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 23:73-88. doi: 10.1016/S0306-4530(97)00064-4
98. Sundström I, Nyberg S, Bäckström T (1997) Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17:370-381. doi: 10.1016/S0893-133X(97)00086-9
99. Sundström I, Andersson A, Nyberg S et al (1998) Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67:126-138. doi: 10.1159/000054307
100. Taniguchi F, Couse JF, Rodriguez KF et al (2007) Estrogen receptor-α mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17α-hydroxylase/17,20 lyase) expression. FASEB J 21:586-595. doi: 10.1096/fj.06-6681com
101. Tiemstra JD, Patel K (1998) Hormonal therapy in the management of premenstrual syndrome. J Am Board Fam Pract 11:378-381. doi: 10.3122/15572625-11-5-378
102. Tomarken AJ, Dichter GS, Garber J, Simien C (2004) Resting frontal brain activity: linkages to maternal depression and socio-economic status among adolescents. Biol Psychol 67:77-102. doi: 10.1016/j.biopsycho.2004.03.011
103. Tuohy A, McVey C (2008) Subscales measuring symptoms of non-specific depression, anhedonia, and anxiety in the Edinburgh Postnatal Depression Scale. Br J Clin Psychol 47:153-169
104. Uzunov DP, Cooper TB, Costa E, Guidotti A (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci 93:12599-12604
105. Uzunova V, Sheline Y, Davis JM et al (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci 95:3239-3244
106. Walf AA, Frye CA (2006) A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31:1097-1111
107. Wang M, Seippel L, Purdy RH, Bãckström T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076-1082. doi: 10.1210/jc.81.3.1076
108. Wieland S, Lan NC, Mirasedeghi S, Gee KW (1991) Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565:263-268. doi: 10.1016/0006-8993(91)91658-N
109. Zhou Y, Watters JJ, Dorsa DM (1996) Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137:2163-2166. doi: 10.1210/en.137.5.2163